Molecular mechanisms of cryptococcal meningitis

Virulence

Volumn 3, Issue 2, 2012, Pages 173-181

  Liu, Tong Bao ^a   Perlin, David S ^a,b   Xue, Chaoyang ^a,b  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Blood brain barrier; Central nervous system; Cryptococcus neoformans; Fungus; Infection; Meningitis

Indexed keywords

BRAIN INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; FUNGAL MENINGITIS; HUMAN; LUNG INFECTION; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; REVIEW;

FILOBASIDIELLA NEOFORMANS; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84862865981     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.18685     Document Type: Review

References (120)

1. Honda H, Warren DK. Central nervous system infections: meningitis and brain abscess. Infect Dis Clin North Am 2009; 23:609-23; PMID:19665086; http://dx.doi.org/10.1016/j.idc.2009.04.009
2. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. N Engl J Med 2006; 354:44-53; PMID:16394301; http://dx.doi.org/10.1056/NEJMra052116
3. Abbott NJ, Ronnback L, Hansson E. Astrocyteendothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7:41-53; PMID:16371949; http://dx.doi.org/10.1038/nrn1824
4. Kim KS. Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol 2008; 6:625-34; PMID:18604221; http://dx.doi.org/10.1038/ nrmicro1952
5. Kim KS. Microbial translocation of the blood-brain barrier. Int J Parasitol 2006; 36:607-14; PMID: 16542662; http://dx.doi.org/10.1016/j.ijpara.2006. 01.013
6. Tuomanen E. Entry of pathogens into the central nervous system. FEMS Microbiol Rev 1996; 18:289-99; PMID:8703507; http://dx.doi.org/10.1111/j. 1574-6976.1996.tb00245.x
7. Klein BS, Tebbets B. Dimorphism and virulence in fungi. Curr Opin Microbiol 2007; 10:314-9; PMID: 17719267; http://dx.doi.org/10.1016/j.mib.2007.04. 002
8. Naggie S, Perfect JR. Molds: hyalohyphomycosis, phaeohyphomycosis, and zygomycosis. [vii-viii.]. Clin Chest Med 2009; 30:337-53; PMID:19375639; http://dx.doi.org/10.1016/j.ccm.2009.02.009
9. Scully EP, Baden LR, Katz JT. Fungal brain infections. Curr Opin Neurol 2008; 21:347-52; PMID:18451721; http://dx.doi.org/10.1097/WCO.0b013e3282fee95b
10. Gottfredsson M, Perfect JR. Fungal meningitis. Semin Neurol 2000; 20:307-22; PMID:11051295; http://dx. doi.org/10.1055/s-2000-9394
11. Perfect JR, Casadevall A. Cryptococcosis. [v-vi.]. Infect Dis Clin North Am2002; 16:837-74; PMID:12512184; http://dx.doi.org/10.1016/S0891-5520(02)00036-3
12. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009; 23:525-30; PMID:19182676; http://dx.doi.org/10.1097/ QAD.0b013e328322ffac
13. Powderly WG. Cryptococcal Meningitis in HIVInfected Patients. Curr Infect Dis Rep 2000; 2:352-7; PMID:11095877; http://dx.doi.org/10.1007/ s11908-000-0015-y
14. Sanfelice F. Contributo alle morfologia e biologia dei blastomiceti che si sviluppano nei succhi di alcuni frutti. Ann Ig 1894; 4:463-95.
15. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120:123-30; PMID: 6377880
16. Ellis D, Pfeiffer T. The ecology of Cryptococcus neoformans. Eur J Epidemiol 1992; 8:321-5; PMID: 1397195; http://dx.doi.org/10.1007/BF00158562
17. Pfeiffer TJ, Ellis DH. Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis. J Med Vet Mycol 1992; 30: 407-8; PMID:1469544; http://dx.doi.org/10.1080/ 02681219280000541
18. Litvintseva AP, Xu J, Mitchell TG. Population structure and ecology of Cryptococcus noformans and Cryptococcus gattii. In: Heitman J, Kozel., T. R., Kwon-Chung, K. J., Perfect, J. R., and Casadevall, A., ed. Cryptococcus: from human pathogen to model yeast. Washington D. C.: ASM Press, 2011:P97-111.
19. Xue C, Tada Y, Dong X, Heitman J. The human fungal pathogen Cryptococcus can complete its sexual cycle during a pathogenic association with plants. Cell Host Microbe 2007; 1:263-73; PMID:18005707; http://dx.doi.org/10.1016/j.chom.2007.05.005
20. Nielsen K, De Obaldia AL, Heitman J. Cryptococcus neoformans mates on pigeon guano: implications for the realized ecological niche and globalization. Eukaryot Cell 2007; 6:949-59; PMID:17449657; http://dx.doi.org/10.1128/EC.00097-07
21. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004; 101:17258-63; PMID:15572442; http:// dx.doi.org/10.1073/pnas.0402981101
22. Byrnes EJ, 3rd, Li W, Lewit Y, Ma H, Voelz K, Ren P, et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 2010; 6:e1000850; PMID: 20421942; http://dx.doi.org/10.1371/journal.ppat. 1000850
23. Kronstad JW, Attarian R, Cadieux B, Choi J, D'Souza CA, Griffiths EJ, et al. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat Rev Microbiol 2011; 9:193-203; PMID:21326274; http://dx.doi.org/10.1038/nrmicro2522
24. Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR, Diezmann S, et al. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 2005; 437:1360-4; PMID:16222245; http://dx.doi.org/10.1038/nature04220
25. Byrnes EJ, 3rd, Li W, Lewit Y, Perfect JR, Carter DA, Cox GM, et al. First reported case of Cryptococcus gattii in the Southeastern USA: implications for travelassociated acquisition of an emerging pathogen. PLoS ONE 2009; 4:e5851; PMID:19516904; http://dx.doi. org/10.1371/journal.pone.0005851
26. Velagapudi R, Hsueh YP, Geunes-Boyer S, Wright JR, Heitman J. Spores as infectious propagules of Cryptococcus neoformans. Infect Immun 2009; 77:4345-55; PMID:19620339; http://dx.doi.org/10.1128/IAI. 00542-09
27. Giles SS, Dagenais TR, Botts MR, Keller NP, Hull CM. Elucidating the pathogenesis of spores from the human fungal pathogen Cryptococcus neoformans. Infect Immun 2009; 77:3491-500; PMID:19451235; http:// dx.doi.org/10.1128/IAI.00334-09
28. Hatch TF. Distribution and deposition of inhaled particles in respiratory tract. Bacteriol Rev 1961; 25:237-40; PMID:13905321
29. Garcia-Hermoso D, Janbon G, Dromer F. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 1999; 37:3204-9; PMID: 10488178
30. Chen LC, Goldman DL, Doering TL, Pirofski L, Casadevall A. Antibody response to Cryptococcus neoformans proteins in rodents and humans. Infect Immun 1999; 67:2218-24; PMID:10225877
31. Eisenman HC, Casadevall A, McClelland EE. New insights on the pathogenesis of invasive Cryptococcus neoformans infection. Curr Infect Dis Rep 2007; 9:457-64; PMID:17999881; http://dx.doi.org/10. 1007/s11908-007-0070-8
32. Feldmesser M, Kress Y, Casadevall A. Intracellular crystal formation as a mechanism of cytotoxicity in murine pulmonary Cryptococcus neoformans infection. Infect Immun 2001; 69:2723-7; PMID:11254641; http://dx.doi.org/10.1128/IAI.69.4.2723-2727.2001
33. Casadevall A, Perfect JR. Cryptococcus neoformans. Washington, DC: ASM Press, 1998.
34. Huffnagle GB, Lipscomb MF. Cells and cytokines in pulmonary cryptococcosis. Res Immunol 1998; 149: 387-96, discussion 512-4; PMID:9720956; http://dx. doi.org/10.1016/S0923-2494(98)80762-1
35. Lortholary O, Improvisi L, Rayhane N, Gray F, Fitting C, Cavaillon JM, et al. Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection. Infect Immun 1999; 67:6314-20; PMID:10569743
36. Feldmesser M, Casadevall A. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J Immunol 1997; 158: 790-9; PMID:8992996
37. Alvarez M, Casadevall A. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol 2006; 16:2161-5; PMID:17084702; http://dx.doi.org/10.1016/j.cub. 2006.09.061
38. Alvarez M, Casadevall A. Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. BMC Immunol 2007; 8:16; PMID:17705844; http://dx. doi.org/10.1186/1471-2172-8-16
39. Ma H, Croudace JE, Lammas DA, May RC. Expulsion of live pathogenic yeast by macrophages. Curr Biol 2006; 16:2156-60; PMID:17084701; http://dx. doi.org/10.1016/j.cub.2006.09.032
40. Johnston SA, May RC. The human fungal pathogen Cryptococcus neoformans escapes macrophages by a phagosome emptying mechanism that is inhibited by Arp2/3 complex-mediated actin polymerisation. PLoS Pathog 2010; 6:e1001041; PMID:20714349; http:// dx.doi.org/10.1371/journal.ppat.1001041
41. Chang YC, Stins MF, McCaffery MJ, Miller GF, Pare DR, Dam T, et al. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun 2004; 72:4985-95; PMID:15321990; http://dx.doi.org/10.1128/IAI. 72.9.4985-4995.2004
42. Kraus PR, Nichols CB, Heitman J. Calcium-and calcineurin-independent roles for calmodulin in Cryptococcus neoformans morphogenesis and hightemperature growth. Eukaryot Cell 2005; 4:1079-87; PMID:15947200; http://dx.doi.org/10.1128/EC.4.6. 1079-1087.2005
43. Gerik KJ, Donlin MJ, Soto CE, Banks AM, Banks IR, Maligie MA, et al. Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans. Mol Microbiol 2005; 58:393-408; PMID: 16194228; http://dx.doi.org/10.1111/j.1365-2958. 2005.04843.x
44. Gerik KJ, Bhimireddy SR, Ryerse JS, Specht CA, Lodge JK. PKC1 is essential for protection against both oxidative and nitrosative stresses, cell integrity, and normal manifestation of virulence factors in the pathogenic fungus Cryptococcus neoformans. Eukaryot Cell 2008; 7:1685-98; PMID:18689526; http://dx. doi.org/10.1128/EC.00146-08
45. Granger DL, Perfect JR, Durack DT. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest 1985; 76: 508-16; PMID:3928681; http://dx.doi.org/10.1172/ JCI112000
46. 2sensing during Cryptococcus neoformans growth, differentiation, and virulence. Curr Biol 2005; 15:2013-20; PMID:16303560; http://dx.doi.org/10.1016/j.cub.2005.09.047
47. Chrisman CJ, Albuquerque P, Guimaraes AJ, Nieves E, Casadevall A. Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages. PLoS Pathog 2011; 7: e1002047; PMID:21637814; http://dx.doi.org/10. 1371/journal.ppat.1002047
48. Jung WH, Sham A, White R, Kronstad JW. Iron regulation of the major virulence factors in the AIDSassociated pathogen Cryptococcus neoformans. PLoS Biol 2006; 4:e410; PMID:17121456; http://dx.doi. org/10.1371/journal.pbio.0040410
49. Syme RM, Bruno TF, Kozel TR, Mody CH. The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody. Infect Immun 1999; 67:4620-7; PMID:10456908
50. Yauch LE, Lam JS, Levitz SM. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog 2006; 2:e120; PMID:17096589; http://dx.doi.org/10.1371/ journal.ppat.0020120
51. Pericolini E, Cenci E, Monari C, De Jesus M, Bistoni F, Casadevall A, et al. Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8. Cell Microbiol 2006; 8:267-75; PMID: 16441437; http://dx.doi.org/10.1111/j.1462-5822. 2005.00619.x
52. Oscarson S, Alpe M, Svahnberg P, Nakouzi A, Casadevall A. Synthesis and immunological studies of glycoconjugates of Cryptococcus neoformans capsular glucuronoxylomannan oligosaccharide structures. Vaccine 2005; 23:3961-72; PMID:15917118; http:// dx.doi.org/10.1016/j.vaccine.2005.02.029
53. Vecchiarelli A, Pericolini E, Gabrielli E, Chow SK, Bistoni F, Cenci E, et al. Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy. Immunotherapy 2011; 3:997-1005; PMID:21843086; http://dx.doi.org/10.2217/imt.11.86
54. Vecchiarelli A. Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol 2000; 38:407-17; PMID:11204878
55. Doering TL, Nosanchuk JD, Roberts WK, Casadevall A. Melanin as a potential cryptococcal defence against microbicidal proteins. Med Mycol 1999; 37:175-81; PMID:10421849
56. Nosanchuk JD, Casadevall A. The contribution of melanin to microbial pathogenesis. Cell Microbiol 2003; 5:203-23; PMID:12675679; http://dx.doi.org/ 10.1046/j.1462-5814.2003.00268.x
57. Zhu X, Williamson PR. Role of laccase in the biology and virulence of Cryptococcus neoformans. FEMS Yeast Res 2004; 5:1-10; PMID:15381117; http://dx.doi. org/10.1016/j.femsyr.2004.04.004
58. Noverr MC, Williamson PR, Fajardo RS, Huffnagle GB. CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect Immun 2004; 72:1693-9; PMID: 14977977; http://dx.doi.org/10.1128/IAI.72.3.1693-1699.2004
59. Bahn YS, Xue C, Idnurm A, Rutherford JC, Heitman J, Cardenas ME. Sensing the environment: lessons from fungi. Nat Rev Microbiol 2007; 5:57-69; PMID: 17170747; http://dx.doi.org/10.1038/nrmicro1578
60. Alspaugh JA, Perfect JR, Heitman J. Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev 1997; 11:3206-17; PMID:9389652; http://dx.doi.org/ 10.1101/gad.11.23.3206
61. Luberto C, Toffaletti DL, Wills EA, Tucker SC, Casadevall A, Perfect JR, et al. Roles for inositolphosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev 2001; 15:201-12; PMID:11157776; http://dx.doi.org/10.1101/gad.856001
62. Shea JM, Del Poeta M. Lipid signaling in pathogenic fungi. Curr Opin Microbiol 2006; 9:352-8; PMID: 16798065; http://dx.doi.org/10.1016/j.mib.2006.06. 003
63. Heung LJ, Luberto C, Plowden A, Hannun YA, Del Poeta M. The sphingolipid pathway regulates Pkc1 through the formation of diacylglycerol in Cryptococcus neoformans. J Biol Chem 2004; 279:21144-53; PMID:15014071; http://dx.doi.org/10.1074/jbc. M312995200
64. Mare L, Iatta R, Montagna MT, Luberto C, Del Poeta M. APP1 transcription is regulated by inositolphosphorylceramide synthase 1-diacylglycerol pathway and is controlled by ATF2 transcription factor in Cryptococcus neoformans. J Biol Chem 2005; 280: 36055-64; PMID:16129666; http://dx.doi.org/10. 1074/jbc.M507285200
65. Heung LJ, Kaiser AE, Luberto C, Del Poeta M. The role and mechanism of diacylglycerol-protein kinase C1 signaling in melanogenesis by Cryptococcus neoformans. J Biol Chem 2005; 280:28547-55; PMID: 15946943; http://dx.doi.org/10.1074/jbc.M503404200
66. Luberto C, Martinez-Marino B, Taraskiewicz D, Bolanos B, Chitano P, Toffaletti DL, et al. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J Clin Invest 2003; 112:1080-94; PMID:14523045
67. Shea JM, Kechichian TB, Luberto C, Del Poeta M. The cryptococcal enzyme inositol phosphosphingolipidphospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system. Infect Immun 2006; 74:5977-88; PMID:16988277; http://dx.doi. org/10.1128/IAI.00768-06
68. Chen SC, Wright LC, Golding JC, Sorrell TC. Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/ transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans. Biochem J 2000; 347:431-9; PMID:10749672; http://dx.doi.org/10. 1042/0264-6021:3470431
69. Wright LC, Santangelo RM, Ganendren R, Payne J, Djordjevic JT, Sorrell TC. Cryptococcal lipid metabolism: phospholipase B1 is implicated in transcellular metabolism of macrophage-derived lipids. Eukaryot Cell 2007; 6:37-47; PMID:17099081; http://dx.doi. org/10.1128/EC.00262-06
70. Santangelo R, Zoellner H, Sorrell T, Wilson C, Donald C, Djordjevic J, et al. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect Immun 2004; 72:2229-39; PMID:15039347; http:// dx.doi.org/10.1128/IAI.72.4.2229-2239.2004
71. Nielsen K, Cox GM, Litvintseva AP, Mylonakis E, Malliaris SD, Benjamin DK, Jr., et al. Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection. Infect Immun 2005; 73:4922-33; PMID:16041006; http:// dx.doi.org/10.1128/IAI.73.8.4922-4933.2005
72. Okagaki LH, Strain AK, Nielsen JN, Charlier C, Baltes NJ, Chretien F, et al. Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog 2010; 6:e1000953; PMID:20585559; http://dx.doi.org/10.1371/journal.ppat.1000953
73. Zaragoza O, Garcia-Rodas R, Nosanchuk JD, Cuenca-Estrella M, Rodriguez-Tudela JL, Casadevall A. Fungal cell gigantism during mammalian infection. PLoS Pathog 2010; 6:e1000945; PMID:20585557; http:// dx.doi.org/10.1371/journal.ppat.1000945
74. Okagaki LH, Wang Y, Ballou ER, O'Meara TR, Bahn YS, Alspaugh JA, et al. Cryptococcal titan cell formation is regulated by G-protein signaling in response to multiple stimuli. Eukaryot Cell 2011.
75. Shi M, Li SS, Zheng C, Jones GJ, Kim KS, Zhou H, et al. Real-time imaging of trapping and ureasedependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest 2010; 120:1683-93; PMID:20424328; http://dx.doi.org/10.1172/JCI41963
76. Chrétien F, Lortholary O, Kansau I, Neuville S, Gray F, Dromer F. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis 2002; 186:522-30; PMID:12195380; http://dx.doi.org/10. 1086/341564
77. Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 2009; 77:120-7; PMID: 18936186; http://dx.doi.org/10.1128/IAI.01065-08
78. Olszewski MA, Noverr MC, Chen GH, Toews GB, Cox GM, Perfect JR, et al. Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol 2004; 164:1761-71; PMID: 15111322; http://dx.doi.org/10.1016/S0002-9440 (10)63734-0
79. Charlier C, Chretien F, Baudrimont M, Mordelet E, Lortholary O, Dromer F. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 2005; 166:421-32; PMID:15681826; http://dx.doi.org/10.1016/S0002-9440(10)62265-1
80. Chen SH, Stins MF, Huang SH, Chen YH, Kwon-Chung KJ, Chang Y, et al. Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol 2003; 52:961-70; PMID:14532340; http://dx.doi.org/10. 1099/jmm.0.05230-0
81. Vu K, Weksler B, Romero I, Couraud PO, Gelli A. Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans. Eukaryot Cell 2009; 8:1803-7; PMID:19767445; http://dx.doi.org/ 10.1128/EC.00240-09
82. Jong A, Wu CH, Shackleford GM, Kwon-Chung KJ, Chang YC, Chen HM, et al. Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell Microbiol 2008; 10:1313-26; PMID:18248627; http://dx.doi. org/10.1111/j.1462-5822.2008.01128.x
83. Huang SH, Long M, Wu CH, Kwon-Chung KJ, Chang YC, Chi F, et al. Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells is mediated through the lipid rafts-endocytic pathway via the dual specificity tyrosine-phosphorylation-regulated kinase 3 (DYRK3). J Biol Chem 2011.
84. Jong A, Wu CH, Prasadarao NV, Kwon-Chung KJ, Chang YC, Ouyang Y, et al. Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells requires protein kinase C-alpha activation. Cell Microbiol 2008; 10:1854-65; PMID:18489726; http://dx.doi.org/10.1111/j.1462-5822.2008.01172.x
85. Feldmesser M, Tucker S, Casadevall A. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol 2001; 9:273-8; PMID:11390242; http://dx.doi.org/10.1016/S0966-842X(01)02035-2
86. Voelz K, May RC. Cryptococcal interactions with the host immune system. Eukaryot Cell 2010; 9:835-46; PMID:20382758; http://dx.doi.org/10.1128/EC. 00039-10
87. Feldmesser M, Kress Y, Novikoff P, Casadevall A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 2000; 68:4225-37; PMID:10858240; http:// dx.doi.org/10.1128/IAI.68.7.4225-4237.2000
88. Kechichian TB, Shea J, Del Poeta M. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. Infect Immun 2007; 75:4792-8; PMID:17664261; http://dx.doi.org/ 10.1128/IAI.00587-07
89. Guerrero A, Jain N, Goldman DL, Fries BC. Phenotypic switching in Cryptococcus neoformans. Microbiology 2006; 152:3-9; PMID:16385110; http://dx. doi.org/10.1099/mic.0.28451-0
90. Jain N, Guerrero A, Fries BC. Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans. FEMS Yeast Res 2006; 6:480-8; PMID:16696644; http://dx.doi.org/10.1111/j.1567-1364.2006.00039.x
91. Xue C, Liu T, Li W, Liu I, Kronstad JW, Seyfang A, et al. Role of an expanded inositol transporter repertoire in Cryptococcus neoformans sexual reproduction and virulence. mBio 2010; 1:e00084-10.
92. Wang Y, Liu TB, Delmas G, Park S, Perlin D, Xue C. Two major inositol transporters and their role in cryptococcal virulence. Eukaryot Cell 2011; 10:618-28; PMID:21398509; http://dx.doi.org/10.1128/EC. 00327-10
93. Fisher SK, Novak JE, Agranoff BW. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 2002; 82:736-54; PMID:12358779; http://dx.doi.org/10.1046/j.1471-4159.2002.01041.x
94. Haris M, Cai K, Singh A, Hariharan H, Reddy R. In vivo mapping of brain myo-inositol. Neuroimage 2011; 54:2079-85; PMID:20951217; http://dx.doi. org/10.1016/j.neuroimage.2010.10.017
95. Barnett JA. The utilization of sugars by yeasts. Adv Carbohydr Chem Biochem 1976; 32:125-234; PMID: 782183; http://dx.doi.org/10.1016/S0065-2318(08) 60337-6
96. Healy ME, Dillavou CL, Taylor GE. Diagnostic medium containing inositol, urea, and caffeic acid for selective growth of Cryptococcus neoformans. J Clin Microbiol 1977; 6:387-91; PMID:334795
97. Lee SC, Dickson DW, Casadevall A. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol 1996; 27:839-47; PMID:8760020; http://dx.doi.org/ 10.1016/S0046-8177(96)90459-1
98. Lee SC, Casadevall A, Dickson DW. Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis. Am J Pathol 1996; 148:1267-74; PMID:8644867
99. Lee A, Toffaletti DL, Tenor J, Soderblom EJ, Thompson JW, Moseley MA, et al. Survival defects of Cryptococcus neoformans mutants exposed to human cerebrospinal fluid result in attenuated virulence in an experimental model of meningitis. Infect Immun 2010; 78:4213-25; PMID:20696827; http://dx.doi. org/10.1128/IAI.00551-10
100. Chayakulkeeree M, Johnston SA, Oei JB, Lev S, Williamson PR, Wilson CF, et al. SEC14 is a specific requirement for secretion of phospholipase B1 and pathogenicity of Cryptococcus neoformans. Mol Microbiol 2011; 80:1088-101; PMID:21453402; http://dx. doi.org/10.1111/j.1365-2958.2011.07632.x
101. Cox GM, McDade HC, Chen SC, Tucker SC, Gottfredsson M, Wright LC, et al. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 2001; 39:166-75; PMID:11123698; http://dx.doi.org/10.1046/j.1365-2958.2001.02236.x
102. Noverr MC, Cox GM, Perfect JR, Huffnagle GB. Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect Immun 2003; 71:1538-47; PMID:12595473; http://dx.doi.org/10.1128/IAI. 71.3.1538-1547.2003
103. Chang YC, Bien CM, Lee H, Espenshade PJ, Kwon-Chung KJ. Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans. Mol Microbiol 2007; 64:614-29; PMID:17462012; http://dx.doi.org/10.1111/j.1365-2958.2007.05676.x
104. Waterman SR, Hacham M, Hu G, Zhu X, Park YD, Shin S, et al. Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans. J Clin Invest 2007; 117:794-802; PMID:17290306; http:// dx.doi.org/10.1172/JCI30006
105. Carroll SF, Guillot L, Qureshi ST. Mammalian model hosts of cryptococcal infection. Comp Med 2007; 57:9-17; PMID:17348287
106. Riera CM, Masih DT, Nobile R. Experimental cryptococcosis in guinea pigs. Mycopathologia 1983; 82:179-84; PMID:6350885; http://dx.doi.org/10. 1007/BF00439224
107. Kirkpatrick WR, Najvar LK, Bocanegra R, Patterson TF, Graybill JR. New guinea pig model of Cryptococcal meningitis. Antimicrob Agents Chemother 2007; 51:3011-3; PMID:17562797; http://dx.doi. org/10.1128/AAC.00085-07
108. Perfect JR, Lang SD, Durack DT. Chronic cryptococcal meningitis: a new experimental model in rabbits. Am J Pathol 1980; 101:177-94; PMID:7004196
109. Perfect JR. Rabbit model of cryptococcal meningitis. In: Zak O, Sande, M. A., ed. Handbook of animal models of infection. London: Academic Press, Inc, 1999:721-76.
110. Lipscomb MF, Lyons CR, Izzo AA, Lovchik J, Wilder JA. Expermental pulmonary cryptococcal infection in mice. In: Zak O, Sande, M. A., ed. Handbook of animal models of infection. London: Academic Press, Inc., 1999:681-6.
111. Goldman DL, Casadevall A, Cho Y, Lee SC. Cryptococcus neoformans meningitis in the rat. Lab Invest 1996; 75:759-70; PMID:8973471
112. Chakrabarti A. Epidemiology of central nervous system mycoses. Neurol India 2007; 55:191-7; PMID:17921647; http://dx.doi.org/10.4103/0028-3886.35679
113. Nadkarni T, Goel A. Aspergilloma of the brain: an overview. J Postgrad Med 2005; 51(Suppl 1):S37-41; PMID:16519254
114. Kantarcioglu AS, de Hoog GS. Infections of the central nervous system by melanized fungi: a review of cases presented between 1999 and 2004. Mycoses 2004; 47:4-13; PMID:14998393; http://dx.doi.org/10. 1046/j.1439-0507.2003.00956.x
115. Perfect JR, Alexander BD, Schell WA. Phaeohyphomycoses. In: Kauffman CA, Pappas, P. G., Sobel, J. D., and Dismukes, W. E., ed. Essential of Clinical Mycology. New York: Springer 2011:305-17.
116. Jong AY, Stins MF, Huang SH, Chen SH, Kim KS. Traversal of Candida albicans across human bloodbrain barrier in vitro. Infect Immun 2001; 69:4536-44; PMID:11401997; http://dx.doi.org/10.1128/IAI. 69.7.4536-4544.2001
117. Liu Y, Mittal R, Solis NV, Prasadarao NV, Filler SG. Mechanisms of Candida albicans Trafficking to the Brain. PLoS Pathog 2011; 7:e1002305; PMID: 21998592; http://dx.doi.org/10.1371/journal.ppat. 1002305
118. Bohse ML, Woods JP. Surface localization of the Yps3p protein of Histoplasma capsulatum. Eukaryot Cell 2005; 4:685-93; PMID:15821128; http://dx.doi. org/10.1128/EC.4.4.685-693.2005
119. Aravalli RN, Hu S, Woods JP, Lokensgard JR. Histoplasma capsulatum yeast phase-specific protein Yps3p induces Toll-like receptor 2 signaling. J Neuroinflammation 2008; 5:30; PMID:18606009; http://dx.doi.org/10.1186/1742-2094-5-30
120. Denning DW, Hope WW. Therapy for fungal diseases: opportunities and priorities. Trends Microbiol 2010; 18:195-204; PMID:20207544; http://dx. doi.org/10.1016/j.tim.2010.02.004